The National Library of Medicine “has links to information on how the United States responds to oil spills, state agencies in the Gulf region that respond to spills, occupational hazards for professionals and volunteers assisting with clean-up, seafood safety and more.”
Archive for the ‘News from NIH’ Category
Crude Oil Spills and Health
Friday, May 7th, 2010Health Resources for Haiti
Tuesday, February 2nd, 2010Health Resources for Haiti is a response to the Haitian disaster prepared by the National Library of Medicine’s Disaster Information Management Research Center. The portal organizes links to a variety of useful information provided by government agencies, NGOs and publishers who have generously made their sites public to aid in this emergency. Topics include management of injuries, infectious diseases, sanitation, environmental health, cultural background and even toxicity of wild plants.
Important News for All NIH Grantholders
Monday, March 3rd, 2008As of April 7, 2008, all recipients of NIH grants must comply with a new policy created to ensure public access to the results of NIH funded research. The full text of such publications will be deposited in PubMed Central, a subset of the freely searchable PubMed bibliographic database.
NIH has provided instructions for facilitating submission of your work including links to a set of user-friendly tutorials.
For additional information, see the Brown University Library Resource Guide for NIH Public Access Policy.
International HIV/AIDS Trial Results
Saturday, March 18th, 2006International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy
From NIH:
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), today announced that enrollment into a large international HIV/AIDS trial comparing continuous antiretroviral therapy with episodic drug treatment guided by levels of CD4+ cells has been stopped. Enrollment was stopped because those patients receiving episodic therapy had twice the risk of disease progression (the development of clinical AIDS or death), the major outcome of the study.
Go to Article